First Acceptance has concluded its 2025 fiscal year with a notable increase in profitability, successfully navigating a strategic change in...

Eterna Therapeutics has drawn significant market attention following a substantial insider purchase and the release of an updated corporate strategy....

As we move into March 2026, the clean energy sector is demonstrating notable resilience in the face of broader global...

A notable divergence has emerged in the market's reaction to Lineage's latest financial report. While sell-side analysts maintain a guarded...

The biopharmaceutical firm Helix BioPharma is intensifying its development of highly targeted cancer treatments. Recent data presentations for its CEACAM6-targeting...

A notable shift in sentiment is emerging around Meridian Bank. Market data reveals a substantial surge in short selling activity...

Shares of defense contractor AeroVironment experienced extreme volatility last week, culminating in a sharp sell-off that has left investors anxious....

The coming year represents a critical juncture for Viking Therapeutics, a biotechnology firm whose clinical pipeline is drawing significant investor...

As Nvidia prepares for its pivotal GPU Technology Conference (GTC), the company is channeling its record-breaking financial strength into a...

While its share price remains significantly depressed from its July 2025 peak, Strategy is adopting a notably aggressive posture. The...